Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × Bevacizumab × Clear all

Craniopharyngioma, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Adenomatous Polyposis Coli, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Desmoid Tumors

NCT01083368 2019-08-21

Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy

Phase 1/2 Completed

22 enrolled 15 charts

Genitourinary

Prostatic Neoplasms

NCT00996502 2019-03-27

Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer

Phase 1/2 Terminated

4 enrolled 2 charts

Genitourinary

Prostatic Neoplasms

NCT00574769 2017-04-11

Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancer

Phase 1/2 Completed

27 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Clinical Trials

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy

Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer

Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancer